Insider Trading & Ownership of Hans Edgar Bishop

Location
Seattle, WA
Summary
The estimated net worth of Hans Edgar Bishop is at least $31,210,394 dollars as of 08 Apr 2026. Hans Edgar Bishop is the Director of Sana Biotechnology, Inc. and owns shares of Sana Biotechnology, Inc. (SANA) stock worth about $16.84M. Hans Edgar Bishop is the Director of Lyell Immunopharma, Inc. and owns shares of Lyell Immunopharma, Inc. (LYEL) stock worth about $10.68M. Hans Edgar Bishop is the Director of AGILENT TECHNOLOGIES, INC. and owns shares of AGILENT TECHNOLOGIES, INC. (A) stock worth about $3.68M.
Signature
/s/ Aaron M. Grossman, Attorney-in-Fact for Hans Edgar Bishop
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Hans Edgar Bishop and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

  • Hans Edgar Bishop has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $31,210,394.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: Sana Biotechnology, Inc. ($16,843,688).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Hans Edgar Bishop

Insider Transactions Reported by Hans Edgar Bishop:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .